HUP0004621A3 - Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailability - Google Patents
Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailabilityInfo
- Publication number
- HUP0004621A3 HUP0004621A3 HU0004621A HUP0004621A HUP0004621A3 HU P0004621 A3 HUP0004621 A3 HU P0004621A3 HU 0004621 A HU0004621 A HU 0004621A HU P0004621 A HUP0004621 A HU P0004621A HU P0004621 A3 HUP0004621 A3 HU P0004621A3
- Authority
- HU
- Hungary
- Prior art keywords
- bioavailability
- protease inhibitor
- hiv protease
- sulfate salt
- oral absorption
- Prior art date
Links
- 229940122440 HIV protease inhibitor Drugs 0.000 title 1
- 238000010521 absorption reaction Methods 0.000 title 1
- 239000004030 hiv protease inhibitor Substances 0.000 title 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4795097P | 1997-05-29 | 1997-05-29 | |
| GBGB9714320.0A GB9714320D0 (en) | 1997-07-07 | 1997-07-07 | Hiv protease inhibitor |
| PCT/US1998/010633 WO1998054178A1 (en) | 1997-05-29 | 1998-05-26 | Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailability |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0004621A2 HUP0004621A2 (en) | 2002-03-28 |
| HUP0004621A3 true HUP0004621A3 (en) | 2002-04-29 |
Family
ID=26311845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0004621A HUP0004621A3 (en) | 1997-05-29 | 1998-05-26 | Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailability |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0986554A1 (en) |
| JP (1) | JP3267632B2 (en) |
| KR (1) | KR20010013042A (en) |
| CN (1) | CN1257497A (en) |
| AU (1) | AU730245B2 (en) |
| BG (1) | BG103923A (en) |
| BR (1) | BR9809498A (en) |
| CA (1) | CA2291086A1 (en) |
| EA (1) | EA199901095A1 (en) |
| EE (1) | EE9900543A (en) |
| HR (1) | HRP980283A2 (en) |
| HU (1) | HUP0004621A3 (en) |
| ID (1) | ID23858A (en) |
| IL (1) | IL132779A0 (en) |
| IS (1) | IS5240A (en) |
| NO (1) | NO995822L (en) |
| PE (1) | PE75099A1 (en) |
| PL (1) | PL336847A1 (en) |
| SK (1) | SK163299A3 (en) |
| TR (1) | TR199902816T2 (en) |
| TW (1) | TW438799B (en) |
| WO (1) | WO1998054178A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2391643C (en) | 1999-11-24 | 2010-01-12 | Merck & Co., Inc. | Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors |
| AU2001290743A1 (en) * | 2000-09-14 | 2002-03-26 | Ortho-Mcneil Pharmaceutical, Inc. | Solid salt forms of n-(2-(4-(2-(1-methylethoxy)phenyl)-1-piperazinyl)ethyl)-2-oxo-1-piperidineacetamide |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1046727C (en) * | 1993-12-15 | 1999-11-24 | 麦克公司 | HIV protease inhibitors |
-
1998
- 1998-05-20 TW TW087107834A patent/TW438799B/en active
- 1998-05-26 CN CN98805372A patent/CN1257497A/en active Pending
- 1998-05-26 EA EA199901095A patent/EA199901095A1/en unknown
- 1998-05-26 EP EP98923741A patent/EP0986554A1/en not_active Withdrawn
- 1998-05-26 WO PCT/US1998/010633 patent/WO1998054178A1/en not_active Application Discontinuation
- 1998-05-26 HU HU0004621A patent/HUP0004621A3/en unknown
- 1998-05-26 ID IDW991462A patent/ID23858A/en unknown
- 1998-05-26 JP JP50079999A patent/JP3267632B2/en not_active Expired - Fee Related
- 1998-05-26 AU AU75959/98A patent/AU730245B2/en not_active Ceased
- 1998-05-26 PL PL98336847A patent/PL336847A1/en unknown
- 1998-05-26 EE EEP199900543A patent/EE9900543A/en unknown
- 1998-05-26 SK SK1632-99A patent/SK163299A3/en unknown
- 1998-05-26 CA CA002291086A patent/CA2291086A1/en not_active Abandoned
- 1998-05-26 TR TR1999/02816T patent/TR199902816T2/en unknown
- 1998-05-26 BR BR9809498-0A patent/BR9809498A/en not_active Application Discontinuation
- 1998-05-26 KR KR1019997011018A patent/KR20010013042A/en not_active Application Discontinuation
- 1998-05-26 IL IL13277998A patent/IL132779A0/en unknown
- 1998-05-28 PE PE1998000432A patent/PE75099A1/en not_active Application Discontinuation
- 1998-05-28 HR HR9714320.0A patent/HRP980283A2/en not_active Application Discontinuation
-
1999
- 1999-11-09 IS IS5240A patent/IS5240A/en unknown
- 1999-11-24 BG BG103923A patent/BG103923A/en unknown
- 1999-11-26 NO NO995822A patent/NO995822L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2291086A1 (en) | 1998-12-03 |
| EP0986554A1 (en) | 2000-03-22 |
| BR9809498A (en) | 2000-06-20 |
| NO995822D0 (en) | 1999-11-26 |
| JP2000513747A (en) | 2000-10-17 |
| HUP0004621A2 (en) | 2002-03-28 |
| JP3267632B2 (en) | 2002-03-18 |
| AU7595998A (en) | 1998-12-30 |
| KR20010013042A (en) | 2001-02-26 |
| IS5240A (en) | 1999-11-09 |
| WO1998054178A1 (en) | 1998-12-03 |
| CN1257497A (en) | 2000-06-21 |
| IL132779A0 (en) | 2001-03-19 |
| TR199902816T2 (en) | 2000-02-21 |
| TW438799B (en) | 2001-06-07 |
| PE75099A1 (en) | 1999-08-11 |
| PL336847A1 (en) | 2000-07-17 |
| BG103923A (en) | 2000-06-30 |
| NO995822L (en) | 2000-01-28 |
| SK163299A3 (en) | 2000-07-11 |
| HRP980283A2 (en) | 1999-08-31 |
| EA199901095A1 (en) | 2000-08-28 |
| AU730245B2 (en) | 2001-03-01 |
| EE9900543A (en) | 2000-06-15 |
| ID23858A (en) | 2000-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300952I2 (en) | Peramivir and pharmaceutically acceptable salts thereof | |
| HUP0101389A3 (en) | Bisulfate salt of hiv protease inhibitor | |
| PL338633A1 (en) | Derivatives of aryloxyarylsuphonylamino hydroxamic acid | |
| EP1039890A4 (en) | Novel salts of metformin and method | |
| PL339551A1 (en) | Derivatives of rezorcin | |
| PL313871A1 (en) | Inhibitors of hiv protease | |
| PL339660A1 (en) | Derivatives of amidocarboxylic acids | |
| PL334846A1 (en) | Sulphamidic inhibitors of metaloproteases | |
| GB9805561D0 (en) | A combination of therapeutic agents | |
| PL338144A1 (en) | Derivatives of dolastatin 15 | |
| PL337725A1 (en) | Inhibitors of proteases | |
| PL340461A1 (en) | Derivatives of isothiazocarboxylic acid | |
| AU8638298A (en) | A piece of jewellery | |
| PL334769A1 (en) | Derivatives of 5-aroylnaphtene | |
| HUP0004621A3 (en) | Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailability | |
| GB9805557D0 (en) | A combination of therapeutic agents | |
| HUP0103309A3 (en) | Novel salts of n-tert-butylhydroxylamine and preparation thereof | |
| AU1867899A (en) | Piece of jewellery | |
| ZA984514B (en) | Hiv protease inhibitor | |
| PL335675A1 (en) | Anticonvulsive derivatives of isoquinolinbenzamide | |
| ZA985064B (en) | Derivatives of pentaerythrits | |
| IL130670A0 (en) | Manufacture of elongate members | |
| EP1041986A4 (en) | Pharmaceutically active compound and methods of use | |
| GB2355384B (en) | A piece of jewellery | |
| LT97098A (en) | Potassium salts of n-propionyl-4-hydroxy-3-nitro-l-phenylalanine and n-propionyl-4-metoxy-3-nitro-dl-phenylalanine having antitumour activity |